Skip to content

Aurobindo Pharma shares trade lower after US FDA slaps 10 observations

The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.

Read More

​ The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said. The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish